Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference
CLEVELAND, May 28, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO) today announced that members of its senior management team will participate in a fireside chat at the Jefferies Global Healthcare
Abeona Therapeutics(ABEO.US) Director Buys US$51,799 in Common Stock
$Abeona Therapeutics(ABEO.US)$ Director Alland Leila purchased 11,000 shares of common stock on May 16, 2024 at an average price of $4.709 for a total value of $51,799.Source: Announcement What is sta
Abeona Therapeutics Is Maintained at Overweight by Cantor Fitzgerald
Abeona Therapeutics Is Maintained at Overweight by Cantor Fitzgerald
Express News | Cantor Fitzgerald Maintains Overweight on Abeona Therapeutics, Lowers Price Target to $21
Abeona Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/16/2024 337.5% Cantor Fitzgerald $28 → $21 Maintains Overweight 04/23/2024 650% Cantor Fitzgerald → $36
Abeona Therapeutics Inc (ABEO) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances ...
Q1 2024 Abeona Therapeutics Inc Earnings Call
Express News | Abeona Therapeutics Shares Are Trading Higher. The Company Reported Q1 Financial Results
ABEONA THERAPEUTICS INC. Q1 Loss Increases, Misses Estimates
Express News | Abeona Therapeutics Estimates That Its Current Cash And Cash Equivalents, Restricted Cash And Short-term Investments Of $62.7M, Credit Facility, And Proceeds Of $75M From Underwritten Offering In May Is Expected To Provide Cash Runway Into 2026
Express News | Abeona Therapeutics Q1 2024 GAAP EPS $(1.16) Misses $(0.51) Estimate
Abeona Therapeutics | 10-Q: Quarterly report
Express News | Abeona Therapeutics Inc - Closed $75 Mln Underwritten Offering in May, Extending Expected Cash Runway Into 2026
Express News | Abeona Therapeutics Q1 EPS USD -1.16
Express News | Abeona Therapeutics Q1 Cash & Investments USD 62.7 Million
Express News | Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress
Abeona Therapeutics 1Q Research and Development Expenses $7.2M >ABEO
Abeona Therapeutics 1Q Research and Development Expenses $7.2M >ABEO
Plunge for Elodie Raises $2.5M+ for Life-Saving Rare Disease Research in Just 7 Years
Celebrities, sports teams, schools and supporters across 20+ locations worldwide take polar plunges to raise awareness and funds for rare genetic skin disorder called EBNEW YORK, May 7, 2024 /PRNewsw
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CLEVELAND, May 07, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in
Abeona Therapeutics Shares Rise After Underwritten Offering Gets Priced
By Dean Seal Shares of Abeona Therapeutics jumped after the company's underwritten offering was priced to raise $75 million. The stock was up 21% at $4.92 in early trading. Shares are about 2% below
No Data